Donate Now
Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community
Text Size controlsNormal font sizeMedium font sizeLarge font size

The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease. We are the largest nonprofit funder of Alzheimer's research. We believe in the value of collaboration and are a catalyst toward the time when we will have disease-modifying treatments, preventive strategies and gold-standard care for all people affected by Alzheimer's disease.

We connect with scientific, academic, government and industry thought-leaders and key stakeholders worldwide. You can learn more about the global effort to defeat Alzheimer’s Disease by visiting these sites:

Locally, extraordinary San Diego researchers are advancing our knowledge.
To learn more about the amazing work going on in our own backyard, visit the Shiley Marcos Alzheimer’s Disease Research Center at UC San Diego.

Clinical Trials

Through clinical trials, researchers test new ways to detect, treat and prevent Alzheimer's disease and dementia. Recruiting and retaining clinical trial participants is now the greatest obstacle, other than funding, to developing the next generation of Alzheimer's treatments.

We need your help. Without participation, finding a cure is virtually impossible.

People with Alzheimer’s, caregivers and healthy volunteers are all needed today to participate in Alzheimer’s and dementia research.When you join a clinical trial, you have an opportunity to participate in vital research that could change the course of this disease and improve the lives of all those it affects. Your participation in clinical trials gives us optimism for today and promise for the future.

Current Clinical Trials in San Diego:

Anti-Amyloid in Asymptomatic Alzheimer's Disease - A4 Trial (ADCS)
A4 is a clinical study for older individuals (ages 65-85) who have normal thinking and memory function but who may be at risk for developing Alzheimer's disease (AD) memory loss sometime in the future. The A4 study is for people without any outward signs of Alzheimer's disease, and is designed to evaluate the effectiveness, safety and tolerability of an investigational drug for AD. The A4 Study will begin to enroll participants at more than 60 sites in the U.S. over the next six months. There are also A4 sites in Canada and Australia.The study lasts for three years, and participants will be assigned at random to receive either the investigational drug or a placebo and will be monitored over that period.

For more information CLICK HERE, or contact Christina Gigliotti, at 858-822-4800 or


Alzheimer's Association TrialMatch®  is a free, easy-to-use clinical studies matching service that connects individuals with Alzheimer's, caregivers, healthy volunteers and physicians with current studies. Our continuously updated database of 130+ Alzheimer's clinical trials includes both pharmacological (drug) and non-pharmacological (non-drug) studies being conducted at nearly 500 trial sites across the country.

By signing up for TrialMatch® you are not making a commitment to participate in a study, but simply signing up to receive more information about trials near you that you may be elegible to take part in. Sign up and get more information today!



Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.